Smartphone App-Based Mindfulness Intervention for French and English Speaker Cancer Survivors

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCanadian Cancer Trials Group

About this trial

There is a need to develop, evaluate, and disseminate self-directed, easily accessible, safe, affordable, and effective psychosocial interventions to people living with cancer (PLWC) post-treatment. Smartphone app-based health interventions are an innovative way to deliver psychosocial cancer-care. The Mindfulness-Based Cancer Survivorship (MBCS) Journey app is a mobile app format of the Mindfulness-based Cancer Recovery program. In the SEAMLESS Study, the investigators aim to evaluate the MBCS Journey app (a 4 week mind-body intervention) in cancer survivors post-treatment. This is a randomized wait-list controlled trial. Participants will either be assigned into the immediate group (will receive intervention immediately after enrollment) or the waitlist group (wait for 3 months before receiving the intervention).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult ≥ 18 years

Diagnosed with any type of cancer (stages I-IV)

Completed primary treatment (i.e. surgery, chemotherapy, radiation therapy) at least 2 weeks (14days) prior. Note: ongoing maintenance therapy, hormone-blocking therapies, intermittent bone-modifying agents, herceptin and targeted therapy with trastuzumab are not exclusionary.

Have access to a smartphone with data or wifi connection.

Disqualifiers

Major communication difficulties at the time of recruitment, as assessed by the research team (e.g. severe hearing impairment or cognitive impairment (score of ≤ 6; as assessed by the centre CRA using the three questions from the Brief Screen for Cognitive Impairment (BSCI)) listed in the screening CRF, which could interfere with completing the intervention and/or the questionnaires (i.e. inability to read or write)

Suffering from untreated Major Depressive Disorder or other psychiatric disorders that would interfere with participation. (Note: Participants will be referred for treatment and invited to call back once in remission).

Previous experience practicing in-person or app-based mindfulness once a week or more within the last year.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mindfulness

    Behavioral

    A psychological behavioral intervention that trains participants in mindfulness techniques, which involves achieving a moment-to-moment non-judgmental awareness of their internal psychosocial-emotional state through meditation and gentle mindful movements.

Treatment groups

345 Participants
are divided into 2 treatment groups
Group A: Immediate MindfulnessExperimental treatment 1 intervention
Group B: Control MindfulnessOther 1 intervention

Trial outcomes

Primary outcomes

1

Calgary Symptoms of Stress Inventory (C-SOSI)

This is a 56 item scale. Each item is rated on a 5-point Likert scale (1-5). A higher score indicates higher levels of stress.

Time frame
3 months

Secondary outcomes

1

Total symptoms of stress from the C-SOSI to determine the impact of the one-month MBCS Journey intervention on stress immediately after the therapeutic intervention at one month from randomization

The C-SOSI refers to the 56-item Calgary Symptoms of Stress Inventory. There are 8 sub-scales (Depression, Anger, Muscle Tension, Cardiopulmonary Arousal, Sympathetic Arousal, Neurological/GI, Cognitive Disorganization, and Upper Respiratory symptoms) plus a TOTAL stress score.

Time frame
1 month after randomization
2

Patient Reported Outcome Measurement Information System (PROMIS) - Anxiety

Short form (4 items). A higher score indicates higher levels of anxiety.

Time frame
3 months
3

Patient Reported Outcome Measurement Information System (PROMIS) - Depression

Short form (4 items). A higher score indicates higher levels of depression.

Time frame
3 months
4

Patient Reported Outcome Measurement Information System (PROMIS) - Fatigue

Short form (4 items). A higher score indicates higher levels of fatigue.

Time frame
3 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Canadian Cancer Trials Group

Lead sponsor

Canadian Institutes of Health Research (CIHR)

Collaborator